An analyser tells you what is in the sample. A sorter has to hand the cells back: alive, pure enough to use, and in a condition that survives what comes next. That difference is why sorter selection goes wrong more often than analyser selection. What sells the instrument is the parameter count. What decides whether the purchase works is the routine that forms around it.
The mechanics of cell sorting are well understood. Cells travel in single file, each is identified by the fluorescence from its markers, and the droplet carrying it is charged and deflected into a tube or a plate well. What differs between instruments is how many colours can be resolved before the panel stops behaving, how much expertise the setup demands, and whether the cells are going into a culture flask or into a patient.
Where the sorted cells are going decides the rest
Downstream use is the first filter. Cells heading for single-cell sequencing tolerate compromises that cells destined for weeks in culture do not. Rare populations shift the emphasis from purity towards recovery, because a beautifully pure sort of too few events is still a failed experiment. Anything that must stay sterile brings the fluid path into the specification. Two questions are worth settling first: what happens to the cells in the hour after the sort, and what happens in the month after.
How many colours the panel actually needs
Parameter count is where most comparisons begin, and where too many stop. The Sony SH800S takes up to four lasers with six fluorescence channels excluding scatter, which covers most routine sorting. The MA900 is the same approach with more room: up to twelve fluorescence channels and two threshold channels rather than one, which is what a complex immunology panel usually needs.
Above that, conventional detection stops being the efficient route. The FP7000 Spectral Cell Sorter is configurable with up to six lasers and 182 detectors, supports panels of more than 44 colours, and sorts up to six ways at event rates of 25,000 events per second. Its optics are matched to the ID7000 spectral analyser, so a panel developed there transfers to the sorter instead of being rebuilt. The harder constraint remains: antigen density, autofluorescence and controls limit a panel long before the detector count does, which is why spectral panel design deserves as much attention as the instrument choice.
Who will be standing in front of the instrument
A sorter run by one experienced operator and one shared by six groups are different purchases. The SH800S calibrates automatically and is ready in under thirty minutes, with less than a minute of hands-on time; the MA900 in under forty-five. That matters most in teaching environments and shared facilities with many occasional users and few specialists.
Two smaller points matter more than they look. Templates move between systems, so a protocol agreed with a group abroad can be reproduced locally. On the FP7000, automated setup covers optical alignment, laser delay, droplet calibration, sort delay and side stream adjustment. When the user list changes every semester, that automation is not a convenience. It is what keeps results comparable across the year.
Biosafety belongs in the specification, not the appendix
Sorting produces droplets, so containment has to be settled early. Work with primary human material, infected cells, microorganisms or viruses usually has to happen under a hood. The SH800S and MA900 are compact enough to sit inside a hood or cabinet where BSL-2 or higher containment is required, a very different planning exercise from building a dedicated sorting suite.
When the particles are smaller than cells
Extracellular vesicles, bacteria and viruses sit near the instrument's detection floor rather than in its comfortable range. On the SH800S and MA900, samples down to 350 nm in diameter have been identified on physical properties, and the FP7000 supports detection of particles as small as 100 nm. Those figures describe the edge of the capability, not its centre. A programme built mainly on sub-micron particles should choose for that specifically, not assume it is covered.
Where a research sorter is the wrong instrument
This is the boundary that costs most when it is noticed late. A research sorter exists to answer scientific questions. Once the sorted cells become part of a therapy given to a patient, the requirements change in kind rather than degree: the fluid path has to be closed so the product is never exposed to the room, the process has to be documented and controlled, and the operation has to sit inside a quality system. The CGX10 Cell Isolation System was built for that, sorting at high speed and high purity in a system closed off from the outside environment, for cell-based immunotherapy and regenerative medicine under GMP-compliant quality and production management.
The reverse is said less often and matters just as much. The CGX10 is not a better research sorter. A discovery group that changes panels every few weeks and chases a new population each month is better served by a research instrument, and a closed clinical platform bought for exploratory work brings constraints the science does not need. Adding standard operating procedures to a research sorter does not make it clinical either. A group expecting to move from discovery into clinical manufacturing should plan for two instruments and a deliberate transfer step.
The choice that still looks right after a year
The best sorter fits the panel a laboratory will really run, the people who will run it, the room it will sit in and the fate of the cells afterwards. Sometimes that is a benchtop system a trained student can start alone. Sometimes it is a spectral platform a core facility builds a service around.
The Sony Biotechnology sorting line, from the benchtop SH800S through to the closed CGX10, is available in Israel from Merkel Technologies. Recovery and viability on the specific cells a laboratory works with are worth settling before an order, because neither appears on a specification sheet.